Synbiotic Supplementation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): A Single-Centre, Double-Blind, Randomised, Placebo-Controlled Trial
In a single-centre, double-blind, randomized, placebo-controlled trial involving 34 patients with symptomatic uncomplicated diverticular disease (SUDD), the addition of a synbiotic formulation (Enterolactis duo) to a high-fibre diet was found to be no more effective than a high-fibre diet plus placebo in improving gastrointestinal symptoms or quality of life.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the human colon, small, pouch-like bulges can form in the wall, much like weak spots in an old tire tube. These are called diverticula, and they are a common occurrence as people age. For many, these pouches cause no trouble at all. However, for a significant number of people, these same structures become the source of recurring pain, bloating, and changes in how the bowel moves, even though there is no active infection or inflammation. This condition is known as symptomatic uncomplicated diverticular disease. It is a frustrating state where the gut feels unwell, yet standard medical scans show no acute crisis. Because the cause is not a simple infection that antibiotics can kill, doctors have long looked to the gut's internal ecosystem—the community of bacteria living inside us—to find answers. The theory is that if the balance of these microscopic residents is off, it might trigger the pain and discomfort. To fix this, scientists have tested whether adding specific helpful bacteria, often paired with a type of fiber that feeds them, could calm the gut and restore comfort.
Researchers at Sapienza University of Rome set out to test this idea with a rigorous experiment involving thirty-four patients who were suffering from this specific type of diverticular pain. The team designed a study where no one knew who was getting the real treatment and who was getting a fake one, a method known as a double-blind trial. The participants were split into two equal groups. Both groups received the same advice to eat a diet rich in fiber, aiming for at least twenty-five grams a day, which is roughly the amount found in a large bowl of oatmeal with fruit and a side of vegetables. Beyond the diet, one group took a daily powder containing a specific strain of beneficial bacteria and a prebiotic fiber called inulin. This combination is called a synbiotic, designed to help the good bacteria survive and thrive. The other group took an identical-looking powder that contained no active ingredients, serving as a placebo. The treatment lasted for twelve weeks, and during that time, the patients kept detailed weekly diaries of their pain, bloating, and bowel habits.
When the twelve weeks were over, the results were clear and somewhat surprising. Both groups, the one taking the bacteria mixture and the one taking the placebo, reported a significant drop in their symptoms. The abdominal pain and bloating that had plagued them lessened noticeably. However, when the researchers compared the two groups directly, there was no difference in how much they improved. The patients who took the synbiotic did not feel better than those who took the fake powder. In fact, the study found that the improvement was likely driven by the attention the patients received, the regular monitoring of their symptoms, and the general focus on their health, rather than the specific bacteria they consumed. Even four weeks after the treatment stopped, the patients in both groups remained stable, with no new advantage appearing for the group that had taken the probiotic.
The study also looked at how well the patients stuck to the dietary advice. Despite being told to eat more fiber, very few participants actually managed to reach the recommended daily amount. This lack of dietary change meant that the researchers were essentially comparing two groups that were both struggling to follow the fiber guidelines, which may have made it harder to see any extra benefit from the bacteria. Furthermore, while the physical symptoms of pain and bloating improved, the patients' overall sense of well-being and quality of life did not change significantly. This suggests that simply easing the gut pain was not enough to lift the overall burden of the disease on a person's daily life. The researchers noted that the small number of people in the study, which was reduced by the global pandemic, meant they could not be absolutely certain that a different result might not appear in a larger group.
Ultimately, this trial did not find evidence that this specific synbiotic supplement is superior to a placebo for treating the pain of symptomatic uncomplicated diverticular disease. The findings challenge the idea that simply adding a specific probiotic and fiber blend is a guaranteed cure for this condition. Instead, the results highlight the complex nature of gut health, where the act of being cared for and monitored can itself lead to real relief. The study concludes that while the gut microbiome remains a promising area for future research, more work is needed to understand exactly which patients might benefit from these treatments and how to help them stick to the necessary dietary changes. For now, the specific combination of bacteria and fiber tested here does not offer a clear advantage over the power of a placebo and attentive care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.